P06537 (GCR_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 150.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Glucocorticoid receptor Short name=GR Alternative name(s): Nuclear receptor subfamily 3 group C member 1 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 783 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth. Involved in chromatin remodeling. Plays a significant role in transactivation By similarity. Ref.14 |
| Subunit structure | Heteromultimeric cytoplasmic complex with HSP90, HSP70, and FKBP5 or another immunophilin, or the immunophilin homolog PPP5C. Directly interacts with UNC45A. Upon ligand binding FKBP5 dissociates from the complex and FKBP4 takes its place, thereby linking the complex to dynein and mediating transport to the nucleus, where the complex dissociates. Binds to DNA as a homodimer, and as heterodimer with NR3C2 or the retinoid X receptor. Binds STAT5A and STAT5B homodimers and heterodimers. Interacts with NRIP1, POU2F1, POU2F2 and TRIM28. Interacts with several coactivator complexes, including the SMARCA4 complex, CREBBP/EP300, TADA2L (Ada complex) and p160 coactivators such as NCOA2 and NCOA6. Interaction with BAG1 inhibits transactivation. Interacts with HEXIM1, PELP1 and TGFB1I1. Interacts with NCOA1, NCOA3, SMARCA4, SMARCC1, SMARCD1, and SMARCE1 By similarity. Ref.5 Ref.6 Ref.7 Ref.8 Ref.9 |
| Subcellular location | Cytoplasm. Mitochondrion By similarity. Nucleus. Note: Cytoplasmic in the absence of ligand, nuclear after ligand-binding. The hormone-occupied receptor undergoes rapid exchange between chromatin and the nucleoplasmic compartment. Ref.8 Ref.9 |
| Induction | |
| Domain | Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. |
| Post-translational modification | Increased proteasome-mediated degradation in response to glucocorticoids. Phosphorylated in the absence of hormone; becomes hyperphosphorylated in the presence of glucocorticoids. Ref.4 Sumoylated; this reduces transcription transactivation By similarity. Ubiquitinated; restricts glucocorticoid-mediated transcriptional signaling. Ref.10 |
| Miscellaneous | T-cell is a critical cellular target of GR, as immune activation in mice lacking GR resulted in significant mortality. This lethal activation is rescued by PTGS2 inhibition but not steroid administration or cytokine neutralization. |
| Sequence similarities | Belongs to the nuclear hormone receptor family. NR3 subfamily. Contains 1 nuclear receptor DNA-binding domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Dync1i1 | O88485 | 2 | EBI-492753,EBI-492834 | |
| Fkbp4 | P30416 | 3 | EBI-492753,EBI-492746 | |
| Fkbp5 | Q64378 | 2 | EBI-492753,EBI-492796 | |
| Hsp90ab1 | P11499 | 2 | EBI-492753,EBI-492813 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing and alternative initiation. [Align] [Select] | ||||||
| Isoform 1 (identifier: P06537-1) Also known as: 1-A; GR form A; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P06537-2) Also known as: 2-A; GR form B; The sequence of this isoform differs from the canonical sequence as follows: 458-458: G → GR | ||||||
| Note: Produced by alternative splicing. | ||||||
| Isoform 1-B (identifier: P06537-3) The sequence of this isoform differs from the canonical sequence as follows: 1-27: Missing. | ||||||
| Note: Produced by alternative initiation at Met-28 of isoform 1. | ||||||
| Isoform 2-B (identifier: P06537-4) The sequence of this isoform differs from the canonical sequence as follows: 1-27: Missing. 458-458: G → GR | ||||||
| Note: Produced by alternative initiation at Met-28 of isoform 2. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 783 | 783 | Glucocorticoid receptor | PRO_0000019939 | ||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||
| DNA binding | 425 – 500 | 76 | Nuclear receptor | |||||||||||||||||||||||||||||||||||||
| Zinc finger | 428 – 448 | 21 | NR C4-type | |||||||||||||||||||||||||||||||||||||
| Zinc finger | 464 – 488 | 25 | NR C4-type | |||||||||||||||||||||||||||||||||||||
| Region | 1 – 427 | 427 | Modulating | |||||||||||||||||||||||||||||||||||||
| Region | 494 – 534 | 41 | Hinge | |||||||||||||||||||||||||||||||||||||
| Region | 535 – 783 | 249 | Steroid-binding | |||||||||||||||||||||||||||||||||||||
| Compositional bias | 75 – 82 | 8 | Poly-Gln | |||||||||||||||||||||||||||||||||||||
| Compositional bias | 407 – 426 | 20 | Glu/Pro/Ser/Thr-rich (PEST region) | |||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 122 | 1 | Phosphoserine Ref.4 | |||||||||||||||||||||||||||||||||||||
| Modified residue | 143 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||
| Modified residue | 150 | 1 | Phosphoserine Ref.4 | |||||||||||||||||||||||||||||||||||||
| Modified residue | 159 | 1 | Phosphothreonine Ref.4 | |||||||||||||||||||||||||||||||||||||
| Modified residue | 212 | 1 | Phosphoserine Ref.4 | |||||||||||||||||||||||||||||||||||||
| Modified residue | 220 | 1 | Phosphoserine Ref.4 | |||||||||||||||||||||||||||||||||||||
| Modified residue | 234 | 1 | Phosphoserine Ref.4 | |||||||||||||||||||||||||||||||||||||
| Modified residue | 275 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||
| Modified residue | 315 | 1 | Phosphoserine Ref.4 | |||||||||||||||||||||||||||||||||||||
| Cross-link | 285 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | ||||||||||||||||||||||||||||||||||||||
| Cross-link | 301 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | ||||||||||||||||||||||||||||||||||||||
| Cross-link | 426 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Probable | ||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 27 | 27 | Missing in isoform 1-B and isoform 2-B. | VSP_018774 | ||||||||||||||||||||||||||||||||||||
| Alternative sequence | 458 | 1 | G → GR in isoform 2 and isoform 2-B. | VSP_003704 | ||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 1 | 1 | M → T: Abolishes expression of A-type isoforms. Ref.11 | |||||||||||||||||||||||||||||||||||||
| Mutagenesis | 28 | 1 | M → T: Abolishes expression of B-type isoforms. 1-B. Ref.11 | |||||||||||||||||||||||||||||||||||||
| Mutagenesis | 426 | 1 | K → A: Abolishes glucocorticoid-mediated degradation and enhances transcription trans-activation. Ref.10 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 437 | 1 | V → G in CAA31738. Ref.2 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 437 | 1 | V → G in CAA31739. Ref.2 | |||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||
| Helix | 538 – 545 | 8 | ||||||||||||||||||||||||||||||||||||||
| Helix | 562 – 585 | 24 | ||||||||||||||||||||||||||||||||||||||
| Helix | 590 – 592 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 595 – 622 | 28 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 625 – 630 | 6 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 633 – 635 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 637 – 640 | 4 | ||||||||||||||||||||||||||||||||||||||
| Turn | 643 – 645 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 646 – 662 | 17 | ||||||||||||||||||||||||||||||||||||||
| Helix | 666 – 677 | 12 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 679 – 682 | 4 | ||||||||||||||||||||||||||||||||||||||
| Helix | 689 – 708 | 20 | ||||||||||||||||||||||||||||||||||||||
| Helix | 714 – 747 | 34 | ||||||||||||||||||||||||||||||||||||||
| Helix | 749 – 751 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 757 – 771 | 15 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 775 – 777 | 3 | ||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| [1] | "The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins." Danielsen M., Northrop J.P., Ringold G.M. EMBO J. 5:2513-2522(1986) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "Novel cDNA sequence possibly generated by alternative splicing of a mouse glucocorticoid receptor gene transcript from Shionogi carcinoma 115." Nohno T., Kasai Y., Saito T. Nucleic Acids Res. 17:445-445(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-755 (ISOFORMS 1 AND 2). |
| [3] | "Regulation of glucocorticoid receptor protein and mRNA levels." Vedeckis W.V., Ali M., Allen H.R. Cancer Res. 49:2295-2302(1989) [PubMed] [Europe PMC] [Abstract] Cited for: GLUCOCORTICOID-MEDIATED DOWN-REGULATION. |
| [4] | "Identification of phosphorylated sites in the mouse glucocorticoid receptor." Bodwell J.E., Orti E., Coull J.M., Pappin D.J.C., Smith L.I., Swift F. J. Biol. Chem. 266:7549-7555(1991) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-122; SER-150; THR-159; SER-212; SER-220; SER-234 AND SER-315. |
| [5] | "Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocortiocoid receptor in mammary cells." Cella N., Groner B., Hynes N.E. Mol. Cell. Biol. 18:1783-1792(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH STA5A AND STAT5B. |
| [6] | "Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression." Chang C.J., Chen Y.L., Lee S.C. Mol. Cell. Biol. 18:5880-5887(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRIM28. |
| [7] | "Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix." Yang L., Guerrero J., Hong H., DeFranco D.B., Stallcup M.R. Mol. Biol. Cell 11:2007-2018(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TGFB1I1. |
| [8] | "The glucocorticoid receptor: rapid exchange with regulatory sites in living cells." McNally J.G., Mueller W.G., Walker D., Wolford R., Hager G.L. Science 287:1262-1265(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, INTERACTION OF REGULATORY PROTEINS WITH TARGET SITES IN CHROMATIN. |
| [9] | "Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus." Galigniana M.D., Radanyi C., Renoir J.-M., Housley P.R., Pratt W.B. J. Biol. Chem. 276:14884-14889(2001) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, HETEROMULTIMERIC COMPLEX FORMATION, INTERACTION WITH FKBP4, MECHANISM OF TRANSLOCATION TO THE NUCLEUS. |
| [10] | "Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids." Wallace A.D., Cidlowski J.A. J. Biol. Chem. 276:42714-42721(2001) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION AT LYS-426, MUTAGENESIS OF LYS-426, GLUCOCORTICOID-MEDIATED DOWN-REGULATION. |
| [11] | "Molecular identification and characterization of A and B forms of the glucocorticoid receptor." Yudt M.R., Cidlowski J.A. Mol. Endocrinol. 15:1093-1103(2001) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE INITIATION, MUTAGENESIS OF MET-1 AND MET-28. |
| [12] | "A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins." Davies T.H., Ning Y.M., Sanchez E.R. J. Biol. Chem. 277:4597-4600(2002) [PubMed] [Europe PMC] [Abstract] Cited for: HETEROMULTIMERIC COMPLEX FORMATION, MECHANISM OF TRANSLOCATION TO THE NUCLEUS. |
| [13] | "T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation." Brewer J.A., Khor B., Vogt S.K., Muglia L.M., Fujiwara H., Haegele K.E., Sleckman B.P., Muglia L.J. Nat. Med. 9:1318-1322(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN IMMUNE SYSTEM DEVELOPMENT. |
| [14] | "Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth." Tronche F., Opherk C., Moriggl R., Kellendonk C., Reimann A., Schwake L., Reichardt H.M., Stangl K., Gau D., Hoeflich A., Beug H., Schmid W., Schuetz G. Genes Dev. 18:492-497(2004) [PubMed] [Europe PMC] [Abstract] Cited for: POSSIBLE FUNCTION IN THE CONTROL OF BODY GROWTH. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X04435 mRNA. Translation: CAA28031.1. X13358 mRNA. Translation: CAA31738.1. X13359 mRNA. Translation: CAA31739.1. | ||||||||||||||||||||||||
| IPI | IPI00125443. IPI00230717. IPI00759971. IPI00856515. | ||||||||||||||||||||||||
| PIR | A25691. | ||||||||||||||||||||||||
| UniGene | Mm.129481. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P06537. | ||||||||||||||||||||||||
| SMR | P06537. Positions 425-782. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-11N. | ||||||||||||||||||||||||
| IntAct | P06537. 4 interactions. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P06537. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P06537. | ||||||||||||||||||||||||
| PRIDE | P06537. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| UCSC | uc008esy.1. mouse. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| MGI | MGI:95824. Nr3c1. | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG270250. | ||||||||||||||||||||||||
| HOGENOM | HOG000037950. | ||||||||||||||||||||||||
| HOVERGEN | HBG007583. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| CleanEx | MM_NR3C1. | ||||||||||||||||||||||||
| Genevestigator | P06537. | ||||||||||||||||||||||||
| GermOnline | ENSMUSG00000024431. Mus musculus. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 1.10.565.10. 1 hit. 3.30.50.10. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR001409. Glcrtcd_rcpt. IPR008946. Nucl_hormone_rcpt_ligand-bd. IPR000536. Nucl_hrmn_rcpt_lig-bd_core. IPR001723. Str_hrmn_rcpt. IPR001628. Znf_hrmn_rcpt. IPR013088. Znf_NHR/GATA. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF02155. GCR. 1 hit. PF00104. Hormone_recep. 1 hit. PF00105. zf-C4. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00528. GLCORTICOIDR. PR00398. STRDHORMONER. PR00047. STROIDFINGER. | ||||||||||||||||||||||||
| SMART | SM00430. HOLI. 1 hit. SM00399. ZnF_C4. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF48508. Str_ncl_receptor. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS00031. NUCLEAR_REC_DBD_1. 1 hit. PS51030. NUCLEAR_REC_DBD_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| BindingDB | P06537. | ||||||||||||||||||||||||
| ChEMBL | CHEMBL3144. | ||||||||||||||||||||||||
| ChiTaRS | NR3C1. mouse. | ||||||||||||||||||||||||
| EvolutionaryTrace | P06537. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | GCR_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P06537 Secondary accession number(s): Q61628, Q61629 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
